Badalona Major Depressive Disorder Database Study

Phase 2b Study of ALTO-100 in MDD

NCT05712187 ·Status: COMPLETED ·Phase: PHASE2

The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder

NCT02749721 ·Status: COMPLETED ·Phase: PHASE4

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

NCT02871297 ·Status: TERMINATED ·Phase: PHASE3

Comparative Responses to 15 Different Antidepressants in Major Depressive Disorder

NCT05952713 ·Status: COMPLETED

Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder

NCT00810069 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)

NCT02433093 ·Status: COMPLETED ·Phase: PHASE1

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

NCT05841030 ·Status: COMPLETED

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

NCT01111565 ·Status: TERMINATED ·Phase: PHASE3

Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation

NCT05866575 ·Status: RECRUITING ·Phase: NA

AZD6765 Severe Major Depressive Disorder (MDD) IV

NCT00781742 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD

NCT00785434 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

NCT01482221 ·Status: COMPLETED ·Phase: PHASE2

Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age

NCT03108625 ·Status: COMPLETED ·Phase: PHASE3

Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression

NCT01305707 ·Status: TERMINATED ·Phase: PHASE4

Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder

NCT06532604 ·Status: NOT_YET_RECRUITING ·Phase: NA

In Vitro Modeling of Drug-resistant Psychiatric Disorders Using Induced Pluripotent Cells

NCT05887310 ·Status: UNKNOWN

This is a Study to Determine the Antidepressant Effects of AZD6765

NCT00986479 ·Status: COMPLETED ·Phase: PHASE2

AZD6765 for Treatment Resistant Depression

NCT00491686 ·Status: COMPLETED ·Phase: PHASE2

Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects

NCT01046630 ·Status: COMPLETED ·Phase: PHASE1

AZD7268 Safety and Tolerability Study

NCT01020799 ·Status: COMPLETED ·Phase: PHASE2

BDNF Gene Polymorphism and Antidepressants Treatment

NCT00308893 ·Status: COMPLETED ·Phase: PHASE4

A Study of ONO-1110 in Patients With Major Depressive Disorder

NCT06792136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder

NCT00432614 ·Status: COMPLETED ·Phase: PHASE3

Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)

NCT01185977 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

NCT01111552 ·Status: TERMINATED ·Phase: PHASE3